A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
68Ga-NODAGA-exendin-4 PET improves the detection of focal congenital hyperinsulinism
Tekijät: Boss Marti, Rottenburger Christof, Brenner Winfried, Blankenstein Oliver, Prasad Vikas, Prasad Sonal, de Coppi Paolo, Kühnen Peter, Buitinga Mijke, Nuutila Pirjo, Otonkoski Timo, Hussain Khalid, Brom Maarten, Eek Annemarie, Bomanji Jamshed, Shah Pratik, Gotthardt Martin
Kustantaja: Society of Nuclear Medicine and Molecular Imaging
Julkaisuvuosi: 2022
Journal: Journal of Nuclear Medicine
Tietokannassa oleva lehden nimi: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Lehden akronyymi: J Nucl Med
ISSN: 0161-5505
eISSN: 1535-5667
DOI: https://doi.org/10.2967/jnumed.121.262327
Verkko-osoite: https://jnm.snmjournals.org/content/63/2/310
Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/67680697
Surgery with curative intent can be offered to Congenital Hyperinsulinism (CHI) patients, provided that the lesion is focal. Radiolabeled Exendin-4 specifically binds the glucagon-like peptide 1 receptor (GLP-1R) on pancreatic beta cells. In this study we compared the performance of [18F]F-DOPA positron emission tomography/computed tomography (DOPA PET) and PET/CT with the new tracer [68Ga]Ga-NODAGA-exendin-4 (Exendin PET) in the preoperative detection of focal CHI. Methods: Nineteen CHI patients underwent both DOPA PET and Exendin PET prior to surgery. The images were evaluated in three settings a) standard clinical reading b) blinded expert reading and c) joined reading. Target (lesion) / non target (normal pancreas) ratio were determined using maximum standard uptake value (SUVmax). Image quality was rated by pediatric surgeons in a questionnaire. Results: Fourteen/nineteen patients having focal lesions underwent surgery. Based on clinical readings, the sensitivity of Exendin PET (100% (CI 77-100%)) was higher than that of DOPA PET (71% (CI 42-92%)). Interobserver agreement between readings was higher for Exendin than for DOPA PET (Fleiss' kappa 0.91 vs. 0.56). Exendin PET provided significantly (P = 0.021) higher target / non target ratios (2.02 ± 0.65 ) than DOPA PET (1.40 ± 0.40). On a five point scale, Pediatric surgeons rated Exendin PET superior to DOPA PET. Conclusion: Exendin PET has higher clinical sensitivity and better interobserver correlation for the detection of focal CHI than DOPA PET. Better contrast and image quality makes Exendin PET superior to DOPA PET in surgeons' intra-operative quest for lesion localization.
Ladattava julkaisu This is an electronic reprint of the original article. |  |
